Duality Advisers’s BioNTech BNTX Stock Holding History

Duality Advisers’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-31,382	Closed	-$3.39M	–	562
2023 Q2	$3.39M	Buy	+31,382	New	+$3.53M	0.43%	62
2023 Q1	–	Sell	-23,440	Closed	-$3.52M	–	571
2022 Q4	$3.52M	Buy	23,440 +13,267	+130%	+$2.04M	0.4%	58
2022 Q3	$1.37M	Sell	10,173 -4,708	-32%	-$720K	0.15%	252
2022 Q2	$2.22M	Buy	+14,881	New	+$2.27M	0.22%	176

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Duality Advisers's BNTX Position: Q3 2023 in Review

Duality Advisers sold out of BioNTech (BNTX) in Q3 2023, closing a stake of 31,382 shares — an estimated $3.39M sold.

Duality Advisers first reported a position in BNTX in Q2 2022 and held it in 4 quarters. The position peaked at $3.52M in Q4 2022. 252 funds tracked by Wall St. Rank hold BNTX as of Q3 2023.

Duality Advisers reported no remaining BioNTech position as of Q3 2023 after selling out during the quarter.
Duality Advisers sold 31,382 BioNTech shares in Q3 2023, an estimated $3.39M.
Duality Advisers first reported a position in BioNTech in Q2 2022 and held it in 4 quarters.
Duality Advisers's BioNTech position peaked at $3.52M in Q4 2022.
252 funds tracked by Wall St. Rank held BioNTech as of Q3 2023.

Based on Duality Advisers's 13F filing for Q3 2023, filed 2 Nov 2023.